Retraction Note: Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1-7 Signals
- PMID: 39145864
- PMCID: PMC12125020
- DOI: 10.1007/s12011-024-04347-6
Retraction Note: Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1-7 Signals
Retraction of
-
Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1-7 Signals.Biol Trace Elem Res. 2023 Apr;201(4):1846-1863. doi: 10.1007/s12011-022-03286-4. Epub 2022 May 19. Biol Trace Elem Res. 2023. Retraction in: Biol Trace Elem Res. 2025 May;203(5):2933. doi: 10.1007/s12011-024-04347-6. PMID: 35590119 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
